Researchers Compare Hypofractionated High-dose IMRT Schedules in Prostate Cancer

Researchers Compare Hypofractionated High-dose IMRT Schedules in Prostate Cancer

For the phase 3 CHHiP trial, researchers sought to explore the dose response relationship for two 3 Gy hypofractionated IMRT schedules for the treatment of T1b-3a N0 localized prostate cancer. Researchers enrolled 3216 men with localized disease and …

(Visited 1 times, 1 visits today)
1
Like
Save

Comments

Comments are disabled for this post.